Al18F-octreotide

Al18F-octreotide · Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Al18F-octreotide, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression [Phase 2, Phase 3]